Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The evidence for a role of B cells in multiple sclerosis.

Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV.

Neurology. 2012 Mar 13;78(11):823-32. doi: 10.1212/WNL.0b013e318249f6f0. Review.

2.
3.

B cells and multiple sclerosis.

Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F.

Lancet Neurol. 2008 Sep;7(9):852-8. doi: 10.1016/S1474-4422(08)70192-3. Review.

PMID:
18703007
4.

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?

Agahozo MC, Peferoen L, Baker D, Amor S.

Mult Scler Relat Disord. 2016 Sep;9:110-7. doi: 10.1016/j.msard.2016.07.011. Epub 2016 Jul 20. Review.

PMID:
27645355
5.

B cell-directed therapies in multiple sclerosis.

Gasperi C, Stüve O, Hemmer B.

Neurodegener Dis Manag. 2016;6(1):37-47. doi: 10.2217/nmt.15.67. Review.

PMID:
26782316
6.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
7.

[Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].

Mesaroc S, Drulović J, Lević Z, Perić V.

Srp Arh Celok Lek. 2003 Jan-Feb;131(1-2):31-5. Serbian.

8.

Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.

Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Alvarez-Cermeño JC.

Mult Scler. 2011 Jun;17(6):690-4. doi: 10.1177/1352458510396922. Epub 2011 Mar 24.

PMID:
21436320
9.

Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

Rolf L, Muris AH, Hupperts R, Damoiseaux J.

Immunology. 2016 Mar;147(3):275-84. doi: 10.1111/imm.12572. Epub 2016 Feb 2. Review.

10.

Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.

Correale J, Gaitán MI.

Acta Neurol Scand. 2015;132(199):46-55. doi: 10.1111/ane.12431. Review.

PMID:
26046559
11.

Epstein-Barr virus and multiple sclerosis.

Salvetti M, Giovannoni G, Aloisi F.

Curr Opin Neurol. 2009 Jun;22(3):201-6. doi: 10.1097/WCO.0b013e32832b4c8d. Review.

PMID:
19359987
12.

Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.

Fernández-Menéndez S, Fernández-Morán M, Fernández-Vega I, Pérez-Álvarez A, Villafani-Echazú J.

J Neurol Sci. 2016 Feb 15;361:213-9. doi: 10.1016/j.jns.2016.01.013. Epub 2016 Jan 6. Review.

PMID:
26810546
13.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G.

Mult Scler. 2015 Jul;21(8):1013-24. doi: 10.1177/1352458514568827. Epub 2015 Feb 13.

PMID:
25680984
14.
15.
16.

Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.

Nemecek A, Zimmermann H, Rübenthaler J, Fleischer V, Paterka M, Luessi F, Müller-Forell W, Zipp F, Siffrin V.

Mult Scler. 2016 Apr;22(4):483-93. doi: 10.1177/1352458515593821. Epub 2015 Jul 10.

PMID:
26163073
17.

Immunology of multiple sclerosis.

Pender MP, Greer JM.

Curr Allergy Asthma Rep. 2007 Jul;7(4):285-92. Review.

PMID:
17547851
18.

Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.

Persson L, Longhi S, Enarsson J, Andersen O, Haghigi S, Nilsson S, Lagging M, Johansson M, Bergström T.

J Clin Virol. 2014 Sep;61(1):107-12. doi: 10.1016/j.jcv.2014.06.011. Epub 2014 Jun 20.

PMID:
25022622
19.

Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.

Skundric DS, Cruikshank WW, Montgomery PC, Lisak RP, Tse HY.

Cytokine. 2015 Oct;75(2):234-48. doi: 10.1016/j.cyto.2015.01.005. Epub 2015 Feb 18.

PMID:
25703787
20.

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.

Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL.

Neurology. 2010 Apr 6;74(14):1127-35. doi: 10.1212/WNL.0b013e3181d865a1. Epub 2010 Mar 10.

Supplemental Content

Support Center